| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 5.892.356.980 $ | 99,77 | 149.921.668 | ||||||
| ELI LILLY & COMPANY | ELI LILLY & COMPANY COM | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 725.598.250 $ | 12,29 | 656.650 | |
| JOHNSON & JOHNSON | JOHNSON & JOHNSON COM | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 518.082.116 $ | 8,77 | 2.299.215 | |
| UNITEDHEALTH GROUP INC | UNITEDHEALTH GROUP INC COM | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 360.310.258 $ | 6,10 | 947.412 | |
| MERCK & COMPANY INC | MERCK & COMPANY INC COM | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 291.631.644 $ | 4,94 | 2.456.466 | |
| GILEAD SCIENCES INC | GILEAD SCIENCES INC COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 247.530.395 $ | 4,19 | 1.841.333 | |
| ABBVIE INC | ABBVIE INC COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 232.529.097 $ | 3,94 | 1.068.019 | |
| AMGEN INC | AMGEN INC COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 198.774.468 $ | 3,37 | 590.203 | |
| THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC COM | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 178.454.596 $ | 3,02 | 362.337 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 161.967.859 $ | 2,74 | 361.907 | |
| PFIZER INC | PFIZER INC COM | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 154.436.291 $ | 2,61 | 5.899.018 | |
| EDWARDS LIFESCIENCES CORP | EDWARDS LIFESCIENCES CORP COM | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 147.948.008 $ | 2,51 | 1.710.975 | |
| DANAHER CORP | DANAHER CORP COM | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 117.847.358 $ | 2,00 | 645.138 | |
| ABBOTT LABORATORIES | ABBOTT LABORATORIES COM | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 116.578.126 $ | 1,97 | 1.361.894 | |
| INTUITIVE SURGICAL INC | INTUITIVE SURGICAL INC COM NEW | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 115.260.884 $ | 1,95 | 271.432 | |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA PHARMACEUTICAL INDUSTRIES LTD SPONSORED ADS | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 110.245.693 $ | 1,87 | 3.121.339 | |
| BOSTON SCIENTIFIC CORP | BOSTON SCIENTIFIC CORP COM | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 93.964.496 $ | 1,59 | 1.945.032 | |
| ELEVANCE HEALTH INC | ELEVANCE HEALTH INC COM | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 92.378.811 $ | 1,56 | 234.947 | |
| ARGENX SE | ARGENX SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 74.398.930 $ | 1,26 | 88.995 | |
| BIOGEN INC | BIOGEN INC COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 71.380.848 $ | 1,21 | 364.188 | |
| ASTRAZENECA PLC | ASTRAZENECA PLC ORD USD0.25 | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 71.361.126 $ | 1,21 | 384.355 | |
| STRYKER CORP | STRYKER CORP COM | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 67.714.115 $ | 1,15 | 221.948 | |
| REVOLUTION MEDICINES INC | REVOLUTION MEDICINES INC COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 56.903.823 $ | 0,96 | 361.340 | |
| HUMANA INC | HUMANA INC COM | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 54.427.371 $ | 0,92 | 178.205 | |
| REGENERON PHARMACEUTICALS INC | REGENERON PHARMACEUTICALS INC COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 53.891.000 $ | 0,91 | 87.659 | |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY COM | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 52.435.547 $ | 0,89 | 917.026 | |
| COGENT BIOSCIENCES INC | COGENT BIOSCIENCES INC COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 49.183.756 $ | 0,83 | 1.406.858 | |
| DEXCOM INC | DEXCOM INC COM | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 48.946.326 $ | 0,83 | 663.769 | |
| WATERS CORP | WATERS CORP COM | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 47.734.903 $ | 0,81 | 124.449 | |
| CYTOKINETICS INC | CYTOKINETICS INC COM NEW | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 44.151.431 $ | 0,75 | 575.188 | |
| PENUMBRA INC | PENUMBRA INC COM | EC | 70975L107 | Long | Börsenkurs (Stufe 1) | 42.402.653 $ | 0,72 | 133.216 | |
| HCA HEALTHCARE INC | HCA HEALTHCARE INC COM | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 42.255.285 $ | 0,72 | 111.627 | |
| INSMED INC | INSMED INC COM PAR $.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 41.924.650 $ | 0,71 | 392.149 | |
| CVS HEALTH CORP | CVS HEALTH CORP COM | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 41.823.961 $ | 0,71 | 459.705 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEUTICALS INC COM | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 41.623.096 $ | 0,70 | 471.276 | |
| GALDERMA GROUP AG | GALDERMA GROUP AG CHF0.01 | EC | CH1335392721 | Long | Modellwert (Stufe 2) | 39.790.711 $ | 0,67 | 188.090 | |
| INCYTE CORP | INCYTE CORP COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 38.325.873 $ | 0,65 | 396.174 | |
| NOVARTIS AG | NOVARTIS AG SPONSORED ADR | EC | 66987V109 | Long | Börsenkurs (Stufe 1) | 37.791.782 $ | 0,64 | 251.660 | |
| PROTAGONIST THERAPEUTICS INC | PROTAGONIST THERAPEUTICS INC COM | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 36.877.820 $ | 0,62 | 370.408 | |
| AGILENT TECHNOLOGIES INC | AGILENT TECHNOLOGIES INC COM | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 36.761.022 $ | 0,62 | 271.239 | |
| IDEXX LABORATORIES INC | IDEXX LABORATORIES INC COM | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 36.686.930 $ | 0,62 | 65.102 | |
| NUVALENT INC | NUVALENT INC COM | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 34.865.688 $ | 0,59 | 315.841 | |
| UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 31.008.749 $ | 0,53 | 55.689 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 28.661.828 $ | 0,49 | 94.913 | |
| BRUKER CORP | BRUKER CORP COM | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 27.793.077 $ | 0,47 | 471.949 | |
| MODERNA INC | MODERNA INC COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 26.464.105 $ | 0,45 | 560.799 | |
| IQVIA HOLDINGS INC | IQVIA HOLDINGS INC COM | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 25.726.230 $ | 0,44 | 141.190 | |
| ILLUMINA INC | ILLUMINA INC COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 23.781.242 $ | 0,40 | 145.933 | |
| MEDLINE INC | MEDLINE INC COM CL A | EC | 58507V107 | Long | Börsenkurs (Stufe 1) | 22.124.247 $ | 0,37 | 605.149 | |
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUTICS INC COM | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 21.660.482 $ | 0,37 | 263.702 | |
| MCKESSON CORP | MCKESSON CORP COM | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 20.480.950 $ | 0,35 | 27.586 | |
| BIOMARIN PHARMACEUTICAL INC | BIOMARIN PHARMACEUTICAL INC COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 18.483.759 $ | 0,31 | 322.635 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 17.888.692 $ | 0,30 | 113.005 | |
| DIANTHUS THERAPEUTICS INC | DIANTHUS THERAPEUTICS INC COM | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 17.344.691 $ | 0,29 | 186.482 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES LTD SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 16.910.011 $ | 0,29 | 563.855 | |
| QUEST DIAGNOSTICS INC | QUEST DIAGNOSTICS INC COM | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 16.604.116 $ | 0,28 | 85.193 | |
| LB PHARMACEUTICALS INC | LB PHARMACEUTICALS INC COM SHS | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 15.876.527 $ | 0,27 | 567.627 | |
| UCB SA | UCB SA NPV | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 15.731.634 $ | 0,27 | 53.577 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTICS INC COM | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 15.499.505 $ | 0,26 | 264.813 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC COM | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 14.625.128 $ | 0,25 | 473.152 | |
| ARCUS BIOSCIENCES INC | ARCUS BIOSCIENCES INC COM | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 14.505.376 $ | 0,25 | 572.430 | |
| MADRIGAL PHARMACEUTICALS INC | MADRIGAL PHARMACEUTICALS INC COM | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 13.718.685 $ | 0,23 | 27.588 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUTICALS INC COM | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 13.005.612 $ | 0,22 | 170.008 | |
| CENCORA INC | CENCORA INC COM | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 12.474.062 $ | 0,21 | 46.310 | |
| EXELIXIS INC | EXELIXIS INC COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 11.693.793 $ | 0,20 | 231.652 | |
| ELANCO ANIMAL HEALTH INC | ELANCO ANIMAL HEALTH INC COM | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 11.525.489 $ | 0,20 | 483.249 | |
| DAIICHI SANKYO COMPANY LTD | DAIICHI SANKYO COMPANY LTD NPV | EC | JP3475350009 | Long | Modellwert (Stufe 2) | 11.340.422 $ | 0,19 | 673.800 | |
| SCHOLAR ROCK HOLDING CORP | SCHOLAR ROCK HOLDING CORP COM | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 11.152.104 $ | 0,19 | 226.209 | |
| ADARX PHARMACEUTICALS INC | ADARX PHARMACEUTICALS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 10.892.297 $ | 0,18 | 769.230 | |
| KAILERA THERAPEUTICS INC | KAILERA THERAPEUTICS INC COMMON STOCK | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 20.466.472 $ | 0,35 | 892.174 | |
| WEST PHARMACEUTICAL SERVICES INC | WEST PHARMACEUTICAL SERVICES INC COM | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 10.496.813 $ | 0,18 | 32.517 | |
| MBX BIOSCIENCES INC | MBX BIOSCIENCES INC COM | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 10.490.525 $ | 0,18 | 333.350 | |
| NATERA INC | NATERA INC COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 10.317.460 $ | 0,17 | 46.190 | |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | CHARLES RIVER LABORATORIES INTERNATIONAL INC COM | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 10.151.746 $ | 0,17 | 56.177 | |
| BIO-TECHNE CORP | BIO-TECHNE CORP COM | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 10.022.044 $ | 0,17 | 193.925 | |
| NOVOCURE LTD | NOVOCURE LTD COM USD0.00 | EC | JE00BYSS4X48 | Long | Börsenkurs (Stufe 1) | 9.785.987 $ | 0,17 | 574.295 | |
| INTELLIA THERAPEUTICS INC | INTELLIA THERAPEUTICS INC COM | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 9.354.383 $ | 0,16 | 664.846 | |
| ERASCA INC | ERASCA INC COM | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 9.114.654 $ | 0,15 | 709.864 | |
| VIRIDIAN THERAPEUTICS INC | VIRIDIAN THERAPEUTICS INC COM | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 9.093.594 $ | 0,15 | 516.095 | |
| GLAUKOS CORP | GLAUKOS CORP COM | EC | 377322102 | Long | Börsenkurs (Stufe 1) | 9.006.953 $ | 0,15 | 87.150 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 8.951.977 $ | 0,15 | 38.178 | |
| BRIGHT MINDS BIOSCIENCES INC | BRIGHT MINDS BIOSCIENCES INC COM NEW | EC | 10919W405 | Long | Börsenkurs (Stufe 1) | 8.424.336 $ | 0,14 | 95.655 | |
| AGIOS PHARMACEUTICALS INC | AGIOS PHARMACEUTICALS INC COM | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 7.985.481 $ | 0,14 | 271.615 | |
| EIKON THERAPEUTICS INC | EIKON THERAPEUTICS INC COM | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 7.830.697 $ | 0,13 | 722.389 | |
| VAXCYTE INC | VAXCYTE INC COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 7.573.893 $ | 0,13 | 147.352 | |
| LARONDE INC | LARONDE INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 7.467.566 $ | 0,13 | 386.520 | |
| METTLER-TOLEDO INTERNATIONAL INC | METTLER-TOLEDO INTERNATIONAL INC COM | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 7.151.954 $ | 0,12 | 6.058 | |
| KARTOS THERAPEUTICS INC | KARTOS THERAPEUTICS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 9.541.094 $ | 0,16 | 2.187.771 | |
| Angitia Biopharmaceuticals Limited | Angitia Biopharmaceuticals Limited | EC | Long | Schätzwert (Stufe 3) | beschränkt | 6.517.075 $ | 0,11 | 658.956 | |
| ENANTA PHARMACEUTICALS INC | ENANTA PHARMACEUTICALS INC COM | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 6.474.733 $ | 0,11 | 492.001 | |
| ALUMIS INC | ALUMIS INC COM | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 6.343.099 $ | 0,11 | 293.662 | |
| IMMUNOME INC | IMMUNOME INC COM | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 6.304.329 $ | 0,11 | 288.792 | |
| MONTE ROSA THERAPEUTICS INC | MONTE ROSA THERAPEUTICS INC COM | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 6.270.973 $ | 0,11 | 318.162 | |
| GENESIS THERAPEUTICS INC | GENESIS THERAPEUTICS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 6.088.399 $ | 0,10 | 823.870 | |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BRIDGEBIO ONCOLOGY THERAPEUTICS INC COM NEW | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 7.920.985 $ | 0,13 | 883.053 | |
| PALVELLA THERAPEUTICS INC | PALVELLA THERAPEUTICS INC COM | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 6.007.817 $ | 0,10 | 50.716 | |
| RADNET INC | RADNET INC COM | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 6.002.793 $ | 0,10 | 108.100 | |
| BRIDGEBIO PHARMA INC | BRIDGEBIO PHARMA INC COM | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 5.762.500 $ | 0,10 | 86.968 | |
| KALVISTA PHARMACEUTICALS INC | KALVISTA PHARMACEUTICALS INC COM | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 5.712.213 $ | 0,10 | 212.587 | |
| BEAM THERAPEUTICS INC | BEAM THERAPEUTICS INC COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 5.532.569 $ | 0,09 | 168.010 | |
| AKTIS ONCOLOGY INC | AKTIS ONCOLOGY INC COM | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 5.527.272 $ | 0,09 | 266.503 | |
| IMMUNOCORE HOLDINGS PLC | IMMUNOCORE HOLDINGS PLC ADS | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 5.451.283 $ | 0,09 | 188.691 | |
| DYNE THERAPEUTICS INC | DYNE THERAPEUTICS INC COM | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 5.391.794 $ | 0,09 | 278.934 | |
| DENALI THERAPEUTICS INC | DENALI THERAPEUTICS INC COM | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 5.299.113 $ | 0,09 | 251.859 | |
| MAZE THERAPEUTICS INC | MAZE THERAPEUTICS INC COM | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 4.880.626 $ | 0,08 | 184.453 | |
| SUMMIT THERAPEUTICS INC | SUMMIT THERAPEUTICS INC COM | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 4.858.352 $ | 0,08 | 276.987 | |
| RELAY THERAPEUTICS INC | RELAY THERAPEUTICS INC COM | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 4.818.546 $ | 0,08 | 342.957 | |
| AVALO THERAPEUTICS INC | AVALO THERAPEUTICS INC COM NEW | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 4.778.381 $ | 0,08 | 299.585 | |
| KODIAK SCIENCES INC | KODIAK SCIENCES INC COM | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 4.722.631 $ | 0,08 | 128.647 | |
| KYMERA THERAPEUTICS INC | KYMERA THERAPEUTICS INC COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 4.410.766 $ | 0,07 | 54.173 | |
| ALCON AG | ALCON AG CHF0.04 | EC | CH0432492467 | Long | Börsenkurs (Stufe 1) | 4.345.508 $ | 0,07 | 65.553 | |
| SAGIMET BIOSCIENCES INC | SAGIMET BIOSCIENCES INC COM SER A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 4.265.969 $ | 0,07 | 585.181 | |
| BIONTECH SE | BIONTECH SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 4.022.320 $ | 0,07 | 41.921 | |
| INSITRO INC | INSITRO INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.964.735 $ | 0,07 | 592.636 | |
| BIOHAVEN LTD | BIOHAVEN LTD COM | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 3.840.640 $ | 0,07 | 348.832 | |
| ZEALAND PHARMA A/S | ZEALAND PHARMA A/S DKK1 | EC | DK0060257814 | Long | Modellwert (Stufe 2) | 3.753.815 $ | 0,06 | 74.091 | |
| PTC THERAPEUTICS INC | PTC THERAPEUTICS INC COM | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 3.615.253 $ | 0,06 | 48.954 | |
| BICARA THERAPEUTICS INC | BICARA THERAPEUTICS INC COM | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 3.482.262 $ | 0,06 | 160.104 | |
| QUANTA DIALYSIS TECHNOLOGIES LTD | QUANTA DIALYSIS TECHNOLOGIES LTD | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.448.605 $ | 0,06 | 80.024.425 | |
| ULTRAGENYX PHARMACEUTICAL INC | ULTRAGENYX PHARMACEUTICAL INC COM | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 3.132.669 $ | 0,05 | 130.855 | |
| MOONLAKE IMMUNOTHERAPEUTICS | MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 3.095.479 $ | 0,05 | 161.391 | |
| UPSTREAM BIO INC | UPSTREAM BIO INC COM | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 2.856.403 $ | 0,05 | 341.675 | |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC COM | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 2.623.231 $ | 0,04 | 1.208.862 | |
| EYEPOINT INC | EYEPOINT INC COM NEW | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 2.532.371 $ | 0,04 | 186.478 | |
| OCULAR THERAPEUTIX INC | OCULAR THERAPEUTIX INC COM | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 2.331.617 $ | 0,04 | 258.781 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENCES LTD COM NPV | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 2.275.904 $ | 0,04 | 345.882 | |
| DEFINIUM THERAPEUTICS INC | DEFINIUM THERAPEUTICS INC COM SHS | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 1.965.800 $ | 0,03 | 81.265 | |
| VOR BIOPHARMA INC | VOR BIOPHARMA INC COM NEW | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 1.722.718 $ | 0,03 | 115.078 | |
| REGENXBIO INC | REGENXBIO INC COM | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 1.504.788 $ | 0,03 | 214.663 | |
| MAPLIGHT THERAPEUTICS INC | MAPLIGHT THERAPEUTICS INC COM | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 1.473.033 $ | 0,02 | 50.257 | |
| CORVUS PHARMACEUTICALS INC | CORVUS PHARMACEUTICALS INC COM | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.370.362 $ | 0,02 | 110.424 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D MOLECULAR THERAPEUTICS INC COM | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 1.251.375 $ | 0,02 | 126.274 | |
| SYNDAX PHARMACEUTICALS INC | SYNDAX PHARMACEUTICALS INC COM | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 1.147.190 $ | 0,02 | 58.560 | |
| ANNEXON INC | ANNEXON INC COM | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 1.022.272 $ | 0,02 | 188.611 | |
| NYXOAH SA | NYXOAH SA NPV | EC | BE0974358906 | Long | Börsenkurs (Stufe 1) | 1.005.330 $ | 0,02 | 337.359 | |
| GOLDFINCH BIO INC | GOLDFINCH BIO INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 934.606 $ | 0,02 | 3.115.353 | |
| ORCHESTRA BIOMED HOLDINGS INC | ORCHESTRA BIOMED HOLDINGS INC COM | EC | 68572M106 | Long | Börsenkurs (Stufe 1) | 805.968 $ | 0,01 | 206.130 | |
| EXO IMAGING INC | EXO IMAGING INC | EP | Long | Schätzwert (Stufe 3) | beschränkt | 666.310 $ | 0,01 | 909.960 | |
| CELLARITY INC | CELLARITY INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 497.833 $ | 0,01 | 858.333 | |
| AFFINIVAX INC | AFFINIVAX INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 449.536 $ | 0,01 | 122.824 | |
| BLUEPRINT MEDICINES CORP | BLUEPRINT MEDICINES CORP NPV | EC | 096CVR048 | Long | Schätzwert (Stufe 3) | 202.860 $ | 0,00 | 204.909 | |
| MIRATI THERAPEUTICS INC | MIRATI THERAPEUTICS INC | EC | 604CVR027 | Long | Schätzwert (Stufe 3) | 180.523 $ | 0,00 | 228.510 | |
| GOSSAMER BIO INC | GOSSAMER BIO INC COM | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 84.324 $ | 0,00 | 365.199 | |
| ARCELLX INC | ARCELLX INC COMMON STOCK | EC | 03940C100 | Long | Modellwert (Stufe 2) | 6.507 $ | 0,00 | 92.964 | |
| SWIFT HEALTH SYSTEMS INC | SWIFT HEALTH SYSTEMS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.791 $ | 0,00 | 1.700 | |
| HOLOGIC INC | HOLOGIC INC | EC | 436CVR021 | Long | Modellwert (Stufe 2) | 1.384 $ | 0,00 | 138.368 | |
| FREQUENCY THERAPEUTICS CVR | FREQUENCY THERAPEUTICS CVR | EC | Long | Schätzwert (Stufe 3) | 4 $ | 0,00 | 428.010 | ||
| Gesamt | 5.892.356.980 $ | 99,77 | 149.921.668 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.